Loading the records…
Loading the records…
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
National Institutes of Health wants bids for "COMBINED SYNOPSIS/SOLICITATION/ (Brand Name or Equ". Bids are due Dec 1, 2026. In the last 2 years, similar work went to 10 or more companies, usually for about $99.0M per award. An award is expected between December 2026 and February 2027.
Put together from the facts on this page; the details and sources are below.
Your briefs and their views: My briefs.
Every notice posted under solicitation 75N98027Q00089 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
is solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold
13 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH OLAO), same NAICS 339112.
Single-winner award sizes (10): middle half $99.0M to $99.0M, median $99.0M; range $71K to $99.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ATLANTIC TRADING LLC | 1 | $99.0M | Dec 6, 2024 |
| PRESTIGE AMERITECH LTD | 1 | $99.0M | Jan 8, 2025 |
| HISCOMP LLC | 1 | $99.0M | Dec 6, 2024 |
| O&M Halyard, Inc | 1 | $99.0M | Dec 6, 2024 |
| MACLEAN-PANEFFORT, LLC | 1 | $99.0M | Dec 6, 2024 |
| 3M COMPANY | 1 | $99.0M | Dec 6, 2024 |
| USA CAPITAL FUND LLC | 1 | $99.0M | Dec 6, 2024 |
| MEDLINE INDUSTRIES, LP | 1 | $99.0M | Dec 6, 2024 |
| MERROW MANUFACTURING LLC | 1 | $99.0M | Dec 6, 2024 |
| IRADIMED CORPORATION | 1 | $71K | Jun 30, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
None of these past winners filed lobbying reports naming Natl Institutes of Health (NIH) since 2024. No sign of an incumbent lobbying push at this agency.
No lobbyist on these filings lists a past Natl Institutes of Health (NIH) job: no revolving-door tie found in these filings. (These are lobbyists the companies pay, not their own staff.)
None of these winners matched a listed company, so PAC and FARA checks did not run.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
No bills named on these filings under National Institutes of Health-related issues.
A bill's title is shown only when the filing's own text names it; filings often cite last Congress's bill numbers.
No rules or proposed rules from the department in the last 12 months.
No executive order in the last 12 months names National Institutes of Health in its title or summary.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
None of the past winners matched a listed company.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.